Ignacio Martin-Loeches Selected Research

Noninvasive Ventilation

1/2023	Timing of intubation and ICU mortality in COVID-19 patients: a retrospective analysis of 4198 critically ill patients during the first and second waves.
1/2021	The Surviving Sepsis Campaign: Research Priorities for Coronavirus Disease 2019 in Critical Illness.
10/2017	Risk Factors for Noninvasive Ventilation Failure in Critically Ill Subjects With Confirmed Influenza Infection.
2/2014	Optimal care and design of the tracheal cuff in the critically ill patient.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ignacio Martin-Loeches Research Topics

Disease

54	Infections 01/2024 - 01/2009
42	Critical Illness (Critically Ill) 03/2024 - 01/2009
38	Ventilator-Associated Pneumonia 03/2024 - 01/2013
37	Sepsis (Septicemia) 02/2024 - 01/2013
36	COVID-19 03/2024 - 01/2020
33	Pneumonia (Pneumonitis) 12/2023 - 03/2009
22	Human Influenza (Influenza) 01/2022 - 01/2010
20	Respiratory Tract Infections (Respiratory Tract Infection) 01/2024 - 11/2015
18	Septic Shock (Toxic Shock Syndrome) 04/2023 - 04/2013
15	Healthcare-Associated Pneumonia 01/2024 - 08/2009
12	Communicable Diseases (Infectious Diseases) 03/2023 - 12/2016
11	Bacterial Pneumonia 01/2024 - 03/2009
9	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2023 - 05/2016
8	Cross Infection (Nosocomial Infection) 03/2024 - 09/2017
7	Respiratory Insufficiency (Respiratory Failure) 12/2023 - 10/2017
7	Shock 02/2023 - 03/2009
6	Inflammation (Inflammations) 01/2021 - 10/2018
4	Candidemia 01/2022 - 11/2018
4	Bacteremia 11/2021 - 05/2019
4	Virus Diseases (Viral Diseases) 03/2021 - 08/2011
3	Chronic Renal Insufficiency 10/2023 - 01/2021
3	Lung Injury 01/2023 - 03/2018
3	Wounds and Injuries (Trauma) 01/2023 - 04/2021
3	Superinfection 10/2022 - 11/2021
3	Coinfection 12/2020 - 02/2011
3	Viral Pneumonia 02/2014 - 05/2011
2	Intraabdominal Infections 01/2024 - 01/2016
2	Burns 11/2023 - 01/2021
2	Frailty 10/2023 - 03/2020
2	Aspergillosis 11/2022 - 01/2022
2	Invasive Pulmonary Aspergillosis 05/2022 - 10/2021
2	Neoplasms (Cancer) 04/2021 - 12/2018
2	Pulmonary Embolism 04/2021 - 01/2015
2	Acute Kidney Injury (Acute Renal Failure) 04/2021 - 03/2009
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021 - 01/2015
2	Fatigue 01/2021 - 01/2020
2	Chronic Obstructive Pulmonary Disease (COPD) 09/2020 - 01/2020
2	Candidiasis (Moniliasis) 09/2019 - 05/2017
2	Brain Death (Brain Dead) 01/2019 - 01/2019
2	Obesity 03/2012 - 02/2011
1	Leukocytosis (Pleocytosis) 05/2024
1	Opportunistic Infections (Opportunistic Infection) 02/2024
1	Urinary Tract Infections (Urinary Tract Infection) 01/2024

Drug/Important Bio-Agent (IBA)

40	Anti-Bacterial Agents (Antibiotics)IBA 04/2023 - 03/2009
23	Biomarkers (Surrogate Marker)IBA 09/2023 - 01/2012
10	CytokinesIBA 01/2023 - 01/2009
8	Oxygen (Dioxygen)IBA 05/2024 - 02/2014
8	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2023 - 03/2012
6	SteroidsIBA 02/2024 - 12/2018
6	tazobactam drug combination ceftolozaneIBA 01/2024 - 12/2019
6	Antiviral Agents (Antivirals)IBA 09/2021 - 01/2011
6	Interleukin-6 (Interleukin 6)IBA 04/2021 - 01/2009
6	ProcalcitoninIBA 01/2021 - 05/2017
5	Meropenem (Merrem)FDA LinkGeneric 02/2023 - 12/2019
5	C-Reactive ProteinIBA 01/2021 - 05/2017
4	AntigensIBA 02/2023 - 01/2021
4	MacrolidesIBA 01/2023 - 09/2015
3	Proteins (Proteins, Gene)FDA Link 02/2023 - 01/2020
3	von Willebrand FactorIBA 10/2021 - 01/2021
3	fibrin fragment D (D-dimer)IBA 01/2021 - 01/2015
3	LactamsIBA 04/2020 - 09/2015
3	Oseltamivir (Tamiflu)FDA Link 01/2020 - 05/2011
3	Immunoglobulins (Immunoglobulin)IBA 01/2018 - 01/2013
3	Immunoglobulin A (IgA)IBA 01/2018 - 11/2013
2	Messenger RNA (mRNA)IBA 07/2023 - 03/2011
2	relebactamIBA 06/2023 - 04/2023
2	Imipenem Drug Combination Cilastatin (Primaxin)FDA Link 06/2023 - 04/2023
2	InterleukinsIBA 04/2023 - 01/2010
2	ThrombomodulinIBA 02/2023 - 10/2021
2	Third Generation CephalosporinsIBA 01/2023 - 04/2020
2	CatecholaminesIBA 01/2023 - 01/2023
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2023 - 01/2011
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2023 - 01/2023
2	Thrombin FDA Link 10/2022 - 10/2021
2	carbapenemaseIBA 08/2022 - 10/2018
2	ceftolozaneIBA 01/2022 - 12/2020
2	Tazobactam FDA LinkGeneric 01/2022 - 12/2020
2	Fibrinogen (Factor I)FDA Link 11/2021 - 01/2021
2	Factor VIII (Coagulation Factor VIII)IBA 10/2021 - 01/2021
2	Interleukin-10 (Interleukin 10)IBA 04/2021 - 10/2018
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 04/2021 - 12/2015
2	GoldIBA 09/2020 - 01/2019
2	Antifungal AgentsIBA 09/2019 - 11/2018
2	Immunoglobulin G (IgG)IBA 01/2018 - 11/2013
1	PlasticsIBA 11/2023
1	omega-Chloroacetophenone (Mace)IBA 10/2023

Therapy/Procedure

53	Therapeutics 02/2024 - 03/2009
44	Artificial Respiration (Mechanical Ventilation) 03/2024 - 03/2009
39	Mechanical Ventilators (Ventilator) 01/2024 - 06/2014
35	Critical Care (Surgical Intensive Care) 02/2024 - 05/2014
11	Length of Stay 03/2022 - 08/2009
9	Resuscitation 01/2023 - 08/2014
4	Precision Medicine 12/2023 - 04/2017
4	Noninvasive Ventilation 01/2023 - 02/2014
3	Extracorporeal Membrane Oxygenation 04/2021 - 01/2018
3	Renal Replacement Therapy (Therapies, Renal Replacement) 04/2021 - 12/2018
2	Duration of Therapy 01/2021 - 12/2020
2	Immunotherapy 12/2020 - 12/2019
2	Ambulatory Care (Outpatient Care) 01/2019 - 04/2016
2	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 10/2018 - 03/2018